Research coauthored by RTI Health Solutions researchers will be presented at the 2020 DIA Global Annual Meeting.
Quantitative benefit-risk assessment: What methods are being used? How far has industry come? Smith MY, Marsh K, Hauber B, DiSantostefano R.
Forum, Wednesday June 17, 2020 4:15pm - 5:30pm
Practical considerations for robust evaluation of risk minimization programs: regulatory, industry, service provider insights. Gilsenan A, Smith M.
Forum, Tuesday June 16, 2020 2:00pm - 3:15pm
Three FDA CBER-sponsored quantitative patient preference studies of biologic treatments to inform regulatory decision making. Irony T, Gonzalez Sepulveda JM, Poulos C, Wilson L.
Session, Monday, June 15, 3:45 - 4:15pm
Leveraging natural language processing techniques for regulatory submissions. Anthony MS.
Session, Tuesday, June 16, 8:00 - 9:15am